Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top
2024 half-year recap: Tell us your trading story
Views 4.8M Contents 438

Market review + position analysis (01/07-05/07 2024)

Quick overview of the market this week:
$NASDAQ 100 Index (.NDX.US)$ Accumulation on Friday;
$S&P 500 Index (.SPX.US)$ Accumulation on Friday;
$Russell 2000 Index (.RUT.US)$ Distribution on Friday.
NDX > SPX > RUT.
Although NDX and SPX currently appear to be high, do not assume a bearish market at the moment for the following reasons: 👇
MSFT and APPL are indeed somewhat overextended, and there is a chance of sideways trading or a slight correction; NVDA currently has a chance to climb to a new level on a new small platform; AMZN and META have just shown strength breaking through historic highs; GOOG and NFLX are still climbing step by step; AMD just broke out of its position of a bullish flag...
RUT's structure is currently very tight, and it is still bullish on its chances of breaking out before an interest rate cut.
Market review + position analysis (01/07-05/07 2024)
Market review + position analysis (01/07-05/07 2024)
Market review + position analysis (01/07-05/07 2024)
Weekly charts:
NDX and SPX are testing or even breaking their limits on the edge, and this situation has a chance to continue for several weeks until it tells us it's no longer possible; RUT is still closely following the 30MA, seemingly waiting for a catalyst.
Market review + position analysis (01/07-05/07 2024)
Market review + position analysis (01/07-05/07 2024)
Market review + position analysis (01/07-05/07 2024)
Market Sentiment:
The proportion of bullish and bearish views has slightly decreased this Wednesday, indicating that market participants are starting to have some doubts about the development in both directions.
The Fear & Greed Index has returned to the neutral range, but the breadth has not yet recovered, mainly due to the increased heat in the price index and options market.
Market review + position analysis (01/07-05/07 2024)
Market review + position analysis (01/07-05/07 2024)
Current position, profit and loss, as well as proportion:
Market review + position analysis (01/07-05/07 2024)
Market review + position analysis (01/07-05/07 2024)
$MARA Holdings (MARA.US)$ (RS 93) $iShares Bitcoin Trust (IBIT.US)$ (RS 61) $Super Micro Computer (SMCI.US)$ (RS 99) Please refer to the 'Weekly Trading Summary' published yesterday.
$Palantir (PLTR.US)$ (RS 96) Continuing the upward trend of last week, after a brief rest on Tuesday and Wednesday, it rose sharply with good trading volume on Friday, with the closing price almost at the highest price. Currently, the price is very close to the previous high, and it is being tracked gradually. The 50MA has caught up with the initial stop loss, and then the stop loss has been slightly raised. It still hasn't completed the 'pendulum effect'.
Market review + position analysis (01/07-05/07 2024)
$Tesla (TSLA.US)$ (RS 87) A few weeks ago, the RS reading was still in the 20s. This week, the RS has reached 87, which says it all. The beast has awakened; it has been rising for 8 consecutive days, and the trading volume in the past five days has remained at a very high level. Obviously, it has entered the running rhythm of the benchmark stocks I have been pursuing. It will continue to run until it can no longer move.
Market review + position analysis (01/07-05/07 2024)
$Shift4 Payments (FOUR.US)$ (RS 78) Recently, for the second time, it tested resistance above the previous gap. This week, it has been consolidating with low trading volume, seemingly building a new setup. Its current behavior is acceptable, and the stop loss remains unchanged. We will continue to observe.
Market review + position analysis (01/07-05/07 2024)
$Netflix (NFLX.US)$ (RS 94) There are 8 trading days left until the financial report. This week, it continued to reach a 52-week high, and it is very close to the historical high. We will continue to observe and wait for an opportunity to reduce positions.
Market review + position analysis (01/07-05/07 2024)
$Carvana (CVNA.US)$ (RS 99) The trading volume was dry this week, and the price became tight. It is a good setup. Next week, we may continue to operate based on its actions.
Market review + position analysis (01/07-05/07 2024)
$Amazon (AMZN.US)$ (RS 93) It has recently broken through the VCP and I like that it closed at the round number price of 200, which is also a historical high. Due to its relatively small volatility, it is fine to hold onto it and continue riding without rushing.
Market review + position analysis (01/07-05/07 2024)
$Kaspi.kz (KSPI.US)$ (RS 89) In the first three days of this week, it seemed to test a new support price and looked very neat. The financial report is scheduled for July 22nd. Let's see if there is an opportunity to continue reducing positions before the report.
Market review + position analysis (01/07-05/07 2024)
$TG Therapeutics (TGTX.US)$ (RS 93) The trading volume was inactive this week. We will continue to observe and see if it can truly break out of this massive accumulation zone.
Market review + position analysis (01/07-05/07 2024)
$Coherent (COHR.US)$ (RS 97) It attempted to move up again on Friday, but the results were not ideal. It may need further consolidation. We will continue to observe, and the stop loss remains unchanged.
Market review + position analysis (01/07-05/07 2024)
$Royal Caribbean (RCL.US)$ (RS 94) Mark-style classic trading case, sell half after obtaining 3 times stop loss profit, riding with zero pressure.
Market review + position analysis (01/07-05/07 2024)
$Western Digital (WDC.US)$ (RS 95) After holding for more than a month and a half, I have to accept that it is currently a "dragging oil bottle" in the positions and will look for opportunities to sell in the short term.
Market review + position analysis (01/07-05/07 2024)
$Crocs (CROX.US)$ (RS 93) Holding for nearly a month and a half, another "dragging oil bottle" in the positions, will look for opportunities to sell in the short term.
Market review + position analysis (01/07-05/07 2024)
$TransMedics (TMDX.US)$ (RS 99) It is already a risk-free ride, but currently RSI has diverged for more than two months. Let's see if it can get rid of this situation next. If any unfavorable actions occur, it will be quickly sold.
Market review + position analysis (01/07-05/07 2024)
Current cash ratio: 7.62%
Market review + position analysis (01/07-05/07 2024)
Next, I will focus on 5-6 names that are already held, with all operations based on the price behavior of the stocks themselves.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
14
1
+0
See Original
Report
279K Views
Comment
Sign in to post a comment